Health Condition 1: H650- Acute serous otitis media Health Condition 2: H710- Cholesteatoma of attic Health Condition 3: H712- Cholesteatoma of mastoid Health Condition 4: M472- Other spondylosis with radiculopathy Health Condition 5: H744- Polyp of middle ear
Conditions
Interventions
Intervention1: Injection Rocuronium Bromide: 60 Patients will be receiving ROCURONIUM 1mg per kg intravenously for mask ventilation and endotracheal intubation
Control Intervention1: Injection Succin
Sponsors
Dr Nisbah Begum
Eligibility
Inclusion criteria
Inclusion criteria: ASA Physical status class 1 and 2. Informed written consent from patient.
Exclusion criteria
Exclusion criteria: Patient refusal, Suspected difficult airways, allergy to the study drug, planned awake tracheal intubation, increased risk of pulmonary aspiration, obese patients, edentulous, hepatic insufficiency, patients with facial hair and cervical spine injuries.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expired tidal volume in millilitresTimepoint: At 30s,60s, and 90s after administration of neuromuscular blocking drug. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-Successful intubation in first attempt. 2-Ease of laryngoscopy-vocal cord movement, limb movement & coughing. 3-Hemodynamic changes.Timepoint: 1-Successful intubation in. first attempt in seconds. 2-Ease of laryngoscopy-vocal cord movement, limb movement & coughing. 3-Hemodynamic changes at 30 seconds, 60 seconds & 90 seconds. | — |
Countries
India
Contacts
Public ContactPushpavathi S H
Karnataka Institute of Medical Sciences
Outcome results
None listed